4/A//SEC Filing
Cashman Christopher Michael 4/A
Accession 0001104659-18-003364
CIK 0001267813other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 8:38 PM ET
Size
5.0 KB
Accession
0001104659-18-003364
Insider Transaction Report
Form 4/AAmended
Cashman Christopher Michael
DirectorPresident and CEO
Transactions
- Award
Common stock
2017-01-17+60,600→ 257,469 total
Footnotes (1)
- [F1]Represents restricted common stock. 20,200 shares of restricted common stock each vest on 1/17/18, 1/17/19, and 1/17/20, respectively. This amendment is being filed to correct the reporting of restricted stock grants moving the report of grant of the restricted stock from Table II to Table I of the report being amended.
Documents
Issuer
MARINUS PHARMACEUTICALS INC
CIK 0001267813
Entity typeother
Related Parties
1- filerCIK 0001615437
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 8:38 PM ET
- Size
- 5.0 KB